Saturday 17 October 2026 Export NAMS’s income statement to Excel — free account

NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V.’s revenue for fiscal 2025 (year ended December 2025) was $22.5 million, down 50.6% from fiscal 2024. In the quarter to June 2026, revenue fell 80.7%, EPS fell 246.7% and free cash flow fell 4.07%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.83 0.79 −3.83%

Follow NAMS

Alert me

Market cap: $2.5B
P/E: 0.0×
Fwd P/E: −17.5×
Dividend yield: —
F-score: 3/9
Altman Z: 27.63
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	3	3	2
ROE Full definition →		(39.94%)	(28.29%)	(29.49%)	(36.81%)
ROA Full definition →		(36.08%)	(24.95%)	(27.43%)	(34.16%)
ROIC Full definition →		(532.55%)	(307.51%)	(484.09%)	0.00%
Return on Tangible Assets Full definition →		(32.78%)	(34.53%)	(36.00%)	(44.24%)
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.21)	(1.25)	(1.17)	(1.16)
Free Cash Flow Full definition →		(144.54)	(148.03)	(142.19)	(143.72)
Capital Expenditures Full definition →		(0.15)	(0.25)	(0.27)	(0.26)
Other line items
Cash ROIC Full definition →		(10.09%)	(11.21%)	(10.92%)	(11.35%)
Accounts Receivable Turnover Full definition →		0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		391.94%	630.28%	598.67%	2,095.87%
Selling, General and Administrative Expense of Revenue Full definition →		283.86%	472.62%	454.92%	1,436.33%
Share Based Compensation of Revenue Full definition →		155.54%	264.08%	275.71%	918.64%
Operating CF/Net income Full definition →		0.65	0.73	0.67	0.55
Depreciation/Fixed assets Full definition →		0.66	0.57	0.61	0.59
Capex/Depreciation Full definition →		(0.70)	(1.12)	(1.17)	(1.07)
Revenue per Share Full definition →		0.30	0.19	0.19	0.06
Operating CF per Share Full definition →		(1.21)	(1.25)	(1.17)	(1.16)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.01	0.01	0.04

Show all line items

Columns are period end dates

Stockrow Weekly